{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:18:23Z","timestamp":1790050703483,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T00:00:00Z","timestamp":1430956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s10875-015-0168-y","type":"journal-article","created":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T03:10:31Z","timestamp":1430881831000},"page":"445-448","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Late-Onset Severe Chronic Active EBV in a Patient for Five\u00a0Years with Mutations in STXBP2 (MUNC18-2) and PRF1 (Perforin 1)"],"prefix":"10.1007","volume":"35","author":[{"given":"Jeffrey I.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Niemela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer L.","family":"Stoddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennichi","family":"Dowdell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,7]]},"reference":[{"key":"168_CR1","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1182\/blood-2010-11-316745","volume":"117","author":"JI Cohen","year":"2011","unstructured":"Cohen JI, Jaffe ES, Dale JK, Pittaluga S, Heslop HE, Rooney CM, et al. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States. Blood. 2011;117:5835\u201349.","journal-title":"Blood"},{"key":"168_CR2","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/ACI.0b013e32834c22f5","volume":"11","author":"AH Filipovich","year":"2011","unstructured":"Filipovich AH. The expanding spectrum of hemophagocytic lymphohistiocytosis. Curr Opin Allergy Clin Immunol. 2011;11:512\u20136.","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"168_CR3","doi-asserted-by":"crossref","first-page":"E4482","DOI":"10.1073\/pnas.1313474110","volume":"110","author":"Y Hackmann","year":"2013","unstructured":"Hackmann Y, Graham SC, Ehl S, H\u00f6ning S, Lehmberg K, Aric\u00f2 M, et al. Syntaxin binding mechanism and disease-causing mutations in Munc18-2. Proc Natl Acad Sci U S A. 2013;110:E4482\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"168_CR4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ajhg.2009.09.005","volume":"85","author":"U Stadt zur","year":"2009","unstructured":"zur Stadt U, Rohr J, Seifert W, Koch F, Grieve S, Pagel J, et al. Familial hemophagocytic lymphohistiocytosis type 5 (FHL-5) is caused by mutations in Munc18-2 and impaired binding to syntaxin 11. Am J Hum Genet. 2009;85:482\u201392.","journal-title":"Am J Hum Genet"},{"key":"168_CR5","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1172\/JCI40732","volume":"119","author":"M C\u00f4te","year":"2009","unstructured":"C\u00f4te M, M\u00e9nager MM, Burgess A, Mahlaoui N, Picard C, Schaffner C, et al. Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells. J Clin Invest. 2009;119:3765\u201373.","journal-title":"J Clin Invest"},{"key":"168_CR6","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1182\/blood-2010-05-282541","volume":"116","author":"M Meeths","year":"2010","unstructured":"Meeths M, Entesarian M, Al-Herz W, Chiang SC, Wood SM, Al-Ateeqi W, et al. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood. 2010;116:2635\u201343.","journal-title":"Blood"},{"key":"168_CR7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1136\/jmg.2009.075341","volume":"47","author":"V Cetica","year":"2010","unstructured":"Cetica V, Santoro A, Gilmour KC, Sieni E, Beutel K, Pende D, et al. STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5. J Med Genet. 2010;47:595\u2013600.","journal-title":"J Med Genet"},{"key":"168_CR8","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1182\/blood-2011-12-398958","volume":"119","author":"J Pagel","year":"2012","unstructured":"Pagel J, Beutel K, Lehmberg K, Koch F, Maul-Pavicic A, Rohlfs AK, et al. Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood. 2012;119:6016\u201324.","journal-title":"Blood"},{"key":"168_CR9","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/INF.0b013e318178d21e","volume":"27","author":"S Ohga","year":"2008","unstructured":"Ohga S, Sanefuji M, Ishimura M, Nomura A, Torisu H, Kira R, et al. Epstein-Barr virus load in cerebrospinal fluid of patients with chronic active Epstein-Barr virus infection. Pediatr Infect Dis J. 2008;27:1027\u201330.","journal-title":"Pediatr Infect Dis J"},{"key":"168_CR10","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3324\/haematol.2010.029389","volume":"95","author":"J Rohr","year":"2010","unstructured":"Rohr J, Beutel K, Maul-Pavicic A, Vraetz T, Thiel J, Warnatz K, et al. Atypical familial hemophagocytic lymphohistiocytosis due to mutations in UNC13D and STXBP2 overlaps with primary immunodeficiency diseases. Haematologica. 2010;95:2080\u20137.","journal-title":"Haematologica"},{"key":"168_CR11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/pbc.22037","volume":"53","author":"K Beutel","year":"2009","unstructured":"Beutel K, Gross-Wieltsch U, Wiesel T, Stadt UZ, Janka G, Wagner HJ. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin. Pediatr Blood Cancer. 2009;53:184\u201390.","journal-title":"Pediatr Blood Cancer"},{"key":"168_CR12","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood-2004-09-3713","volume":"106","author":"C Trambas","year":"2005","unstructured":"Trambas C, Gallo F, Pende D, Marcenaro S, Moretta L, De Fusco C, et al. A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood. 2005;106:932\u20137.","journal-title":"Blood"},{"key":"168_CR13","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1182\/blood-2007-02-072850","volume":"110","author":"I Voskoboinik","year":"2007","unstructured":"Voskoboinik I, Sutton VR, Ciccone A, House CM, Chia J, Darcy PK, et al. Perforin activity and immune homeostasis: the common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood. 2007;110:1184\u201390.","journal-title":"Blood"},{"key":"168_CR14","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1182\/blood-2011-07-370148","volume":"118","author":"K Zhang","year":"2011","unstructured":"Zhang K, Jordan MB, Marsh RA, Johnson JA, Kissell D, Meller J, et al. Hypomorphic mutations in PRF1, MUNC13-4, and STXBP2 are associated with adult-onset familial HLH. Blood. 2011;118:5794\u20138.","journal-title":"Blood"},{"key":"168_CR15","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1182\/blood-2014-05-573105","volume":"124","author":"K Zhang","year":"2014","unstructured":"Zhang K, Chandrakasan S, Chapman H, Valencia CA, Husami A, Kissell D, et al. Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood. 2014;124:1331\u20134.","journal-title":"Blood"},{"key":"168_CR16","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood-2003-06-2171","volume":"103","author":"H Katano","year":"2004","unstructured":"Katano H, Ali MA, Patera AC, Catalfamo M, Jaffe ES, Kimura H, et al. Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood. 2004;103:1244\u201352.","journal-title":"Blood"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-015-0168-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-015-0168-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-015-0168-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T04:15:00Z","timestamp":1559276100000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-015-0168-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,7]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["168"],"URL":"https:\/\/doi.org\/10.1007\/s10875-015-0168-y","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,7]]}}}